{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:47:33Z","timestamp":1794293253200,"version":"4.9.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hyperglycemia diagnosed during pregnancy is most commonly due to gestational diabetes mellitus (GDM), while a minority of cases are attributable to previously unrecognized type 2 diabetes mellitus (T2DM) or, more rarely, type 1 diabetes mellitus (T1DM). Although T1DM has traditionally been associated with onset during childhood or adolescence, recent evidence shows that nearly 40% of new T1DM cases occur after the age of 30\u202fyears, coinciding with the age at which many women in Europe begin pregnancy. This highlights the importance of considering T1DM in the differential diagnosis of hyperglycemia during pregnancy, given the relevant implications for the management and outcomes of these pregnancies. Diabetes-related autoantibodies have been detected in pregnancies complicated by GDM, with prevalence varying widely (from less than 1% to up to 18%), depending on population risk, assay, and antibody type. The most commonly detected autoantibodies in GDM are islet cell antibodies (ICA) and anti-glutamic acid decarboxylase antibodies (GADA), while the presence of multiple autoantibodies is much rarer. Women with hyperglycemia and diabetes-related autoimmunity display a peculiar clinical profile: they usually have a normal pre-pregnancy BMI, low insulin resistance, and require insulin therapy more often than antibody-negative patients with hyperglycemia. They are typically younger and are likely to have a family history of diabetes or other autoimmune diseases. Importantly, the presence, and especially the number, of positive autoantibodies is associated with an increased risk of progression to T1DM after pregnancy. Therefore, identifying autoimmune markers of beta-cell damage in pregnant women with hyperglycemia is critical for prognosis, tailored management, and appropriate follow-up.<\/jats:p>","DOI":"10.3389\/fmed.2025.1656833","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:44:54Z","timestamp":1757655894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Type 1 diabetes diagnosed during pregnancy\u2014an unusual but important challenge: a case series and review of literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Amelia","family":"Caretto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Laurenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Bolamperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cellai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Girardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Dozio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scavini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"5","author":"McIntyre","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.7326\/M23-1707","article-title":"Age at diagnosis in U.S. adults with type 1 diabetes","volume":"176","author":"Fang","year":"2023","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.2337\/dc25-S015","article-title":"Management of Diabetes in pregnancy: standards of Care in Diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"ref4","volume-title":"Standard italiani per la cura del diabete mellito","year":"2018"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine society, and the American diabetes association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.beem.2010.06.002","article-title":"Onset of autoimmune type 1 diabetes during pregnancy: prevalence and outcomes","volume":"24","author":"Wucher","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2337\/diacare.26.4.1199","article-title":"Diabetes and abnormal glucose tolerance in women with previous gestational diabetes","volume":"26","author":"Albareda","year":"2003","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2337\/diab.46.9.1459","article-title":"Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study","volume":"46","author":"Fuchtenbusch","year":"1997","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2337\/diacare.20.1.81","article-title":"Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus","volume":"20","author":"Dozio","year":"1997","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1046\/j.1464-5491.2003.00721.x","article-title":"Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to \u03b2-cell antigens","volume":"20","author":"Bo","year":"2003","journal-title":"Diabet Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.numecd.2009.04.004","article-title":"Diabetes related autoimmunity in gestational diabetes mellitus: is it important?","volume":"19","author":"Lapolla","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1477-7827-6-24","article-title":"Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report","volume":"6","author":"Murgia","year":"2008","journal-title":"Reprod Biol Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2337\/diacare.29.03.06.dc05-1118","article-title":"Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies","volume":"29","author":"J\u00e4rvel\u00e4","year":"2006","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.2337\/dc07-s204","article-title":"Diabetes-related autoantibodies and gestational diabetes","volume":"30","author":"de Leiva","year":"2007","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s40618-018-0830-3","article-title":"Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up","volume":"41","author":"Cossu","year":"2018","journal-title":"J Endocrinol Investig"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s12020-016-0932-7","article-title":"The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes","volume":"53","author":"Dereke","year":"2016","journal-title":"Endocrine"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/dme.12629","article-title":"Zinc transporter 8 autoantibodies: what is their clinical relevance in gestational diabetes?","volume":"32","author":"Rudland","year":"2015","journal-title":"Diabet Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1286375","DOI":"10.3389\/fendo.2023.1286375","article-title":"Autoantibodies predict type 1 diabetes after gestational diabetes\u2014a 23-year cohort study","volume":"14","author":"Luiro","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.2337\/dc07-0157","article-title":"Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes","volume":"30","author":"Nilsson","year":"2007","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00586458","article-title":"Type 1 (insulin-dependent) diabetes mellitus diagnosed during pregnancy: a clinical and prognostic study","volume":"33","author":"Buschard","year":"1990","journal-title":"Diabetologia"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabet.2010.07.005","article-title":"Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes","volume":"37","author":"Wucher","year":"2011","journal-title":"Diabetes Metab"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.2169\/internalmedicine.1188-18","article-title":"Type 1 diabetes mellitus diagnosed during follow-up of gestational diabetes mellitus in the early postpartum period","volume":"57","author":"Ikeoka","year":"2018","journal-title":"Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"920861","DOI":"10.1155\/2013\/920861","article-title":"Adult-onset type 1 diabetes and pregnancy: three case reports","volume":"2013","author":"Bonsembiante","year":"2013","journal-title":"Case Rep Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","article-title":"Latent autoimmune diabetes in adults (LADA) should be less latent","volume":"48","author":"Fourlanos","year":"2005","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.36171\/jamd23.26.2.7","article-title":"Il LADA, un diabete di tipo 1.5?","volume":"26","author":"Patti","year":"2023","journal-title":"JAMD"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2337\/diacare.26.2.452","article-title":"Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression","volume":"26","author":"Hossz\u00fafalusi","year":"2003","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/cei\/uxad139","article-title":"A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8","volume":"215","author":"Williams","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"12080","DOI":"10.26355\/eurrev_202312_34806","article-title":"Saliva-based diagnostic approach for diabetes mellitus: a step towards non-invasive detection\u2014a scoping review","volume":"202327","author":"Cenzato","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1656833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:44:55Z","timestamp":1757655895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1656833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":29,"alternative-id":["10.3389\/fmed.2025.1656833"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1656833","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fmed.2025.1656833.s001","asserted-by":"subject"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"article-number":"1656833"}}